MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$189,637K
Proceeds from issuance of
common stock in...
$6,782K
Employee stock purchase
plan purchases
$425K
Proceeds from exercises
of common stock...
$6K
Net cash provided by
financing activities
$194,446K
Canceled cashflow
$2,404K
Net (decrease)
increase in cash, cash...
-$20,297K
Canceled cashflow
$194,446K
Equity-based compensation
expense
$16,914K
Change in fair value of
derivative liabilities
-$6,050K
Accrued expenses and
other current and...
$4,050K
Non-cash lease expense
$2,371K
Depreciation and
amortization expense
$1,636K
Proceeds from sales and
maturities of...
-$178,500K
Proceeds from sale of
property and equipment
$85K
Payments of common stock
and pre-funded...
$1,681K
Payments of principal
portion of finance lease...
$723K
Net cash used in
operating activities
-$156,289K
Canceled cashflow
$31,021K
Net cash used in
investing activities
-$58,454K
Canceled cashflow
$178,585K
Net loss
-$174,325K
Prepaid expenses and
other current and...
$7,993K
Amortization of discount on
available-for-sale securities
$1,874K
Change in operating
lease liability
-$1,786K
Accounts payable
-$1,093K
Other
$239K
Purchases of
available-for-sale securities
$235,886K
Purchases of property and
equipment
$1,153K
Back
Back
Cash Flow
source: myfinsight.com
Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. (SLDB)